Home » Topics » Conferences

Conferences
RSS

Fibrinogen as marker of joint health in patients with severe hemophilia

Feb. 7, 2022

ETV6 and FYB1 rare genetic mutations tied to inherited thrombocytopenia

Feb. 7, 2022

Novel mutations in the FGG gene tied to thrombosis and dysfibrinogenemia

Feb. 7, 2022

Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma

Feb. 3, 2022

AB1 protein targets TP53-mutated gastrointestinal tumors

Jan. 25, 2022

KIN-3248 shows efficacy against tumors with clinically relevant FGFR mutations

Jan. 25, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

YAP1/TAZ signaling plays a role in colorectal cancer

Jan. 25, 2022

TACH-101 shows activity in gastric and colorectal cancer models

Jan. 24, 2022

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...